A Tipping Point for CIRM? Reform Recommendations Coincide with Pressing Problems
California's Little Hoover Commission's sweeping report on the state's $3 billion stem cell agency comes at a time when the ambitious research enterprise could be facing a tipping point in its short life.
Recent weeks have seen several significant developments involving the California Institute for Regenerative Medicine (CIRM), which is less than five ye…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.